IP Library Granted Patent US 7,141,248
Granted Patent B2
US 7,141,248 · App. 10/444,268 · Granted Nov 28, 2006

Methods of producing intraocular lenses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,141,248
App. No.
10/444,268
Granted
Nov 28, 2006
Kind
B2
Abstract

Methods of producing an intraocular lens include introducing a solution into a lens forming enclosure, wherein the solution comprises discrete crosslinkable units of a size small enough to provide an optically clear solution while contributing to a high refractive index of at least 1.3, performing crosslinking between the units of the solution, and thereby forming a solid lens in the enclosure, optionally under a forming pressure.

Claims (15)

1. A method of producing an intraocular lens including: (i) introducing a solution into a lens forming enclosure, said solution comprising discrete crosslinkable units comprising macromolecular particles of a size small enough to provide an optically clear solution while contributing to a high refractive index of at least 1.39; (ii) performing crosslinking between said units of the solution; and thereby (iii) forming a solid lens in said enclosure, optionally under a forming pressure.

2. A method according to claim 1 wherein said crosslinking is initiated by exposing a photoinitiator which is soluble in said solution to light.

3. A method according to claim 2 , wherein said crosslinkable units are macromolecular particles having a size range between about 20 to 160 nm.

4. A method according claim 2 , wherein said solution has a sufficiently low viscosity to be injected with a conventional cannula into said forming enclosure.

5. A method according to claim 1 , wherein the formed lens is an elastically deformable lens with a modulus in the range of about 0.1 to 20 kPa.

6. A method according to claim 2 , wherein said crosslinking reaction is initiated by light of a wavelength above about 305 nm.

7. A method according to claim 4 , wherein said solution is an ophthalmically acceptable aqueous solution.

8. A method according to claim 7 wherein the aqueous solution comprises a water soluble photoinitiator.

9. A method according to claim 8 , wherein the soluble photoinitiator comprises at least one photoactive compound attached to a water soluble macromolecule.

10. A method according to claim 3 , wherein said macromolecular particles are provided with functional groups for crosslinking.

11. A method according to claim 10 , wherein the functional groups comprise vinylic, acrylic or methacrylic groups.

12. A method according to claim 10 , wherein the macromolecular particles are water soluble.

13. A method according to claim 12 , wherein the macromolecular particles comprise units derived from vinyl lactams and/or acrylamides, of which at least one unit contributes to provide a solution of the particles with a refractive index of at least 1.39 and at least one unit contributes to provide the particles with hydrophilic overall characteristics.

14. A method according to claim 13 , wherein said vinyl lactam is N-vinylpyrrolidone.

15. A method according to claim 13 , wherein said acrylamide is N,N-dimethylacrylamide.

Assignments (3)
RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 14961/0242 Recorded Apr 4, 2007
From: BANK OF AMERICA, N.A.
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 019111/0871 →
CHANGE OF NAME Recorded Oct 27, 2005
From: PHARMACIA GRONINGEN B.V.
To: AMO GRONINGEN B.V.
Reel/Frame 016692/0911 →
SECURITY AGREEMENT Recorded Aug 3, 2004
From: ADVANCED MEDICAL OPTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 014961/0242 →